Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Terry A. Jacobson, Debra A. Wertz, Andreas Kuznik & Mark Cziraky. (2013) Cardiovascular event rates in atorvastatin patients versus patients switching from atorvastatin to simvastatin. Current Medical Research and Opinion 29:7, pages 773-781.
Read now
Read now
Roschelle Heuberger. (2012) Polypharmacy and Food–Drug Interactions Among Older Persons: A Review. Journal of Nutrition in Gerontology and Geriatrics 31:4, pages 325-403.
Read now
Read now
Tiina Sairanen1, Pirkka Vikatmaa2, Juha-Matti Lindholm1, Maarit Venermo, Mauri Lepäntalo2 & Turgut Tatlisumak1. (2012) Medical treatment of carotid endarterectomy patients requires attention. Neurological Research 34:6, pages 595-600.
Read now
Read now
Josemir W Sander, Philippe Ryvlin, Hermann Stefan, Daniel R Booth & Jürgen Bauer. (2010) Generic substitution of antiepileptic drugs. Expert Review of Neurotherapeutics 10:12, pages 1887-1898.
Read now
Read now
Michael Lipsitz, Thomas E. Delea & Amy Guo. (2010) Cost effectiveness of letrozole versus anastrozole in postmenopausal women with HR+ early-stage breast cancer. Current Medical Research and Opinion 26:10, pages 2315-2328.
Read now
Read now
Dale A. Rublee & James P. Burke. (2010) LDL-C Goal Attainment in Patients who Remain on Atorvastatin or Switch to Equivalent or Non-equivalent Doses of Simvastatin: A Retrospective Matched Cohort Study in Clinical Practice. Postgraduate Medicine 122:2, pages 16-24.
Read now
Read now
Articles from other publishers (11)
Valeria Belleudi, Francesco Trotta, Simona Vecchi, Laura Amato, Antonio Addis & Marina Davoli. (2018) Studies on drug switchability showed heterogeneity in methodological approaches: a scoping review. Journal of Clinical Epidemiology 101, pages 5-16.
Crossref
Crossref
Giorgio L. Colombo, Enrico Agabiti-Rosei, Alberto Margonato, Claudio Mencacci, Carlo Maurizio Montecucco, Roberto Trevisan & Alberico L. Catapano. (2016) Impact of substitution among generic drugs on persistence and adherence: A retrospective claims data study from 2 Local Healthcare Units in the Lombardy Region of Italy. Atherosclerosis Supplements 21, pages 1-8.
Crossref
Crossref
Ruben G.W. Quek, Kathleen M. Fox, Li Wang, Lu Li, Shravanthi R. Gandra & Nathan D. Wong. (2016) A US Claims-Based Analysis of Real-World Lipid-Lowering Treatment Patterns in Patients With High Cardiovascular Disease Risk or a Previous Coronary Event. The American Journal of Cardiology 117:4, pages 495-500.
Crossref
Crossref
Yasunari Mano, Shota Fukushima, Hisayuki Kuroda, Hiroyuki Ohshima, Yoshinori Kato, Kaori Ohuchi, Kayoko Maezawa, Yasuyuki Momose, Shunya Ikeda & Mariko Asahi. (2015) Adherence to changing from brand-name to generic atorvastatin in newly treated patients: a retrospective cohort study using health insurance claims. Journal of Pharmaceutical Health Care and Sciences 1:1.
Crossref
Crossref
Robert J. Romanelli & Jodi B. Segal. (2014) Predictors of Statin Compliance after Switching from Branded to Generic Agents among Managed-Care Beneficiaries. Journal of General Internal Medicine 29:10, pages 1372-1378.
Crossref
Crossref
Robert J. Romanelli, Trevor Jukes & Jodi B. Segal. (2014) Compliance after switching from branded to generic statins. Pharmacoepidemiology and Drug Safety 23:10, pages 1093-1100.
Crossref
Crossref
Charlotte Olesen, Philipp Harbig, Ishay Barat & Else Marie Damsgaard. (2013) Generic substitution does not seem to affect adherence negatively in elderly polypharmacy patients. Pharmacoepidemiology and Drug Safety 22:10, pages 1093-1098.
Crossref
Crossref
Danny Liew, Kate Webb, Sophie Marbaix & Lieven Annemans. (2012) Changes to the Statin Prescribing Policy in Belgium. American Journal Cardiovascular Drugs 12:4, pages 225-232.
Crossref
Crossref
Danny Liew, Kate Webb, Sophie Marbaix & Lieven Annemans. (2012) Changes to the Statin Prescribing Policy in Belgium. American Journal of Cardiovascular Drugs 12:4, pages 225-232.
Crossref
Crossref
D. Liew, K. Webb, W.-J. Meerding, E. Buskens & J. W. Jukema. (2012) Potential cardiovascular consequences of switching from atorvastatin to generic simvastatin in the Netherlands. Netherlands Heart Journal 20:5, pages 197-201.
Crossref
Crossref
Barbara J Turner, Christopher S Hollenbeak, Mark Weiner & Simon SK Tang. (2011) A Retrospective Cohort Study of the Potency of lipid-lowering therapy and Race-gender Differences in LDL cholesterol control. BMC Cardiovascular Disorders 11:1.
Crossref
Crossref